BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17557186)

  • 1. Practical identifiability of HIV dynamics models.
    Guedj J; Thiébaut R; Commenges D
    Bull Math Biol; 2007 Nov; 69(8):2493-513. PubMed ID: 17557186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameter identifiability and estimation of HIV/AIDS dynamic models.
    Wu H; Zhu H; Miao H; Perelson AS
    Bull Math Biol; 2008 Apr; 70(3):785-99. PubMed ID: 18247096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach to parameter estimation in HIV dynamical models.
    Putter H; Heisterkamp SH; Lange JM; de Wolf F
    Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model selection and mixed-effects modeling of HIV infection dynamics.
    Bortz DM; Nelson PW
    Bull Math Biol; 2006 Nov; 68(8):2005-25. PubMed ID: 16900456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Score tests for exploring complex models: application to HIV dynamics models.
    Drylewicz J; Commenges D; Thiébaut R
    Biom J; 2010 Feb; 52(1):10-21. PubMed ID: 19937998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modeling approach to the impact of HIV mutations on the immune system.
    Vergu E; Mallet A; Golmard JL
    Comput Biol Med; 2005 Jan; 35(1):1-24. PubMed ID: 15567349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum likelihood estimation in dynamical models of HIV.
    Guedj J; Thiébaut R; Commenges D
    Biometrics; 2007 Dec; 63(4):1198-206. PubMed ID: 17489970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical identifiability of model parameters by combined respirometric-titrimetric measurements.
    Petersen B; Gernaey K; Vanrolleghem PA
    Water Sci Technol; 2001; 43(7):347-55. PubMed ID: 11385867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the behavior of solutions in viral dynamical models.
    Tuckwell HC; Wan FY
    Biosystems; 2004 Mar; 73(3):157-61. PubMed ID: 15026192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural identifiability of PBPK models: practical consequences for modeling strategies and study designs.
    Slob W; Janssen PH; van den Hof JM
    Crit Rev Toxicol; 1997 May; 27(3):261-72. PubMed ID: 9189655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV dynamics and immunosenescence.
    Getz WM
    AIDS; 2008 Jan; 22(2):307-9. PubMed ID: 18097234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of HIV-1 kinetic models using quantitative discrimination analysis.
    Knorr AL; Srivastava R
    Bioinformatics; 2005 Apr; 21(8):1668-77. PubMed ID: 15613395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood.
    Raue A; Kreutz C; Maiwald T; Bachmann J; Schilling M; Klingmüller U; Timmer J
    Bioinformatics; 2009 Aug; 25(15):1923-9. PubMed ID: 19505944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical analysis of a two strain HIV/AIDS model with antiretroviral treatment.
    Bhunu CP; Garira W; Magombedze G
    Acta Biotheor; 2009 Sep; 57(3):361-81. PubMed ID: 19357968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing parameter identifiability by model-based experimentation.
    Raue A; Kreutz C; Maiwald T; Klingmuller U; Timmer J
    IET Syst Biol; 2011 Mar; 5(2):120-30. PubMed ID: 21405200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
    Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective automatic procedure for testing parameter identifiability of HIV/AIDS models.
    Saccomani MP
    Bull Math Biol; 2011 Aug; 73(8):1734-53. PubMed ID: 20953911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.